Orphazyme A/S (ORPHA.CO)
DKK 1120.0
(-2.61%)
DKK 1120.0
(-2.61%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -20.02 Thousand | -104.51 Million | -602.57 Million | -539.07 Million | -326.81 Million | -234.76 Million |
| Net Income | -26.04 Thousand | -38.3 Million | -626.53 Million | -633.24 Million | -335.95 Million | -231.65 Million |
| Depreciation & Amortization | - | 782 Thousand | 18.11 Million | 5.2 Million | 3.8 Million | 1.36 Million |
| Deferred income taxes | - | -8.24 Million | -4.94 Million | -1.91 Million | 707 Thousand | - |
| Stock-based compensation | 126.00 | 1773.00 | 16.01 Million | 28.1 Thousand | 2550.00 | 2.1 Million |
| Change in working capital | 10.65 Thousand | -3.17 Million | -932 Thousand | 48.26 Million | 2.07 Million | -8.63 Million |
| Other non-cash items | -4750.00 | -55.57 Million | -4.28 Million | 14.51 Million | 1000.00 | 2.05 Million |
| Investing Cash Flow | -6944.00 | 90.34 Million | 46 Thousand | -5.1 Million | -3.28 Million | -2.34 Million |
| Investments in PPE | - | - | -994 Thousand | -5.1 Million | -3.28 Million | -2.34 Million |
| Acquisitions | - | 1.46 Million | 1.04 Million | - | - | - |
| Investment purchases | -6.94 Million | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -6944.00 | 88.88 Million | 138.00 | -2736.00 | -508.00 | -1603.00 |
| Financing Cash Flow | -685.00 | -35.07 Million | -30.34 Million | 1.15 Billion | 58.93 Million | - |
| Debt repayment | - | -39.15 Million | -29.16 Million | -10.53 Million | -62.75 Million | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -3020.00 | - | - | - | - | - |
| Common Stock Issuance | 2.33 Million | 5.31 Million | 464 Thousand | 1.28 Billion | 19 Thousand | - |
| Other Financing Activities | 2335.00 | 5310.00 | -1.64 Million | -110.82 Million | 121.67 Million | - |
| Accounts receivables | 4.18 Million | 1.11 Million | 2.82 Million | -33.66 Million | 4.92 Million | -14.57 Million |
| Accounts payables | -657 Thousand | -7.79 Million | -3.75 Million | 76.42 Million | -2.84 Million | 1.9 Million |
| Inventory | - | - | -2.82 Million | 33.66 Million | -4.92 Million | - |
| Other working capital | 10.65 Thousand | 3.5 Million | 2.82 Million | -28.16 Million | 4.92 Million | -10.54 Million |
| Cash at beginning of period | 38.91 Thousand | 102.25 Million | 726.92 Million | 123.58 Million | 394.7 Million | 631.73 Million |
| Cash at end of period | 11.26 Thousand | 38.91 Million | 102.25 Million | 726.92 Million | 123.58 Million | 394.7 Million |
| Capital Expenditure | - | - | -994 Thousand | -5.1 Million | -3.28 Million | -2.34 Million |
| Effect of forex changes on cash | 1.00 | 523.00 | 8.19 Million | -11.9 Million | 46 Thousand | 81 Thousand |
| Net cash flow / Change in cash | -27.64 Thousand | -63.33 Million | -624.67 Million | 603.34 Million | -271.11 Million | -237.02 Million |
| Free Cash Flow | -20.02 Thousand | -104.51 Million | -603.56 Million | -544.17 Million | -330.1 Million | -237.11 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 924.00 | 924.00 | -13.26 Million | -26.04 Million | -6632.00 | -12.78 Million |
| Depreciation & Amortization | - | - | - | - | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | 63.00 | 126.00 | 63.00 | - |
| Change in working capital | -1153.50 | -1153.50 | 1.42 Million | 527 Thousand | 1286.50 | -894 Thousand |
| Other non-cash items | 85.00 | 85.00 | -474 Thousand | 1.97 Million | 1334.00 | 2.44 Million |
| Investing Cash Flow | 1496.50 | 1496.50 | -6.94 Million | -6.94 Million | -3472.00 | - |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | -2.96 Million | - | -6.94 Million | -6.94 Million | - | - |
| Sales/Maturities of investments | 5.95 Million | - | - | - | - | - |
| Other Investing Activities | 1496.50 | 1496.50 | -3472.00 | -6944.00 | -3472.00 | - |
| Financing Cash Flow | - | - | -685 Thousand | -685 Thousand | -342.50 | - |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | -3.02 Million | -3.02 Million | -1510.00 | - |
| Common Stock Issuance | - | - | 2.33 Million | 2.33 Million | - | - |
| Other Financing Activities | - | - | 1167.50 | 2335.00 | 1167.50 | - |
| Accounts receivables | 501.00 | 501.00 | -3.89 Million | 4.18 Million | -4039.00 | 8.07 Million |
| Accounts payables | -3.3 Million | - | 8.31 Million | -657 Thousand | - | -8.97 Million |
| Inventory | - | - | 1.00 | - | - | - |
| Other working capital | -1654.50 | -1654.50 | -2.99 Million | -2.99 Million | 5325.50 | 1.00 |
| Cash at beginning of period | 11.26 Million | - | 30.34 Million | 38.91 Million | - | 42.46 Million |
| Cash at end of period | 13.97 Million | 1352.00 | 11.26 Million | 11.26 Million | -7762.50 | 30.34 Million |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | - | 0.50 | 1.00 | 0.50 | - |
| Net cash flow / Change in cash | 2.7 Million | 1352.00 | -19.07 Million | -27.64 Million | -7762.50 | -12.12 Million |
| Free Cash Flow | -144.50 | -144.50 | -7.89 Million | -20.02 Million | -3948.50 | -12.12 Million |
GOLDIAM
LEE
9577
JAYAGROGN
600616
APN